These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 28339092)
1. MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression. Duan J; Chen L; Zhou M; Zhang J; Sun L; Huang N; Bin J; Liao Y; Liao W Oncol Rep; 2017 May; 37(5):2583-2592. PubMed ID: 28339092 [TBL] [Abstract][Full Text] [Related]
2. MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer. Wang C; Wen Z; Xie J; Zhao Y; Zhao L; Zhang S; Liu Y; Xue Y; Shi M Biochem Biophys Res Commun; 2017 Apr; 485(3):665-671. PubMed ID: 28235486 [TBL] [Abstract][Full Text] [Related]
3. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2. Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023 [TBL] [Abstract][Full Text] [Related]
4. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Wang L; Wu Y; Lin L; Liu P; Huang H; Liao W; Zheng D; Zuo Q; Sun L; Huang N; Shi M; Liao Y; Liao W Int J Cancer; 2013 Sep; 133(6):1419-30. PubMed ID: 23457029 [TBL] [Abstract][Full Text] [Related]
5. Voltage-gated sodium channel Nav 1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1. Xia J; Huang N; Huang H; Sun L; Dong S; Su J; Zhang J; Wang L; Lin L; Shi M; Bin J; Liao Y; Li N; Liao W Int J Cancer; 2016 Dec; 139(11):2553-69. PubMed ID: 27529686 [TBL] [Abstract][Full Text] [Related]
6. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer. He W; Liang B; Wang C; Li S; Zhao Y; Huang Q; Liu Z; Yao Z; Wu Q; Liao W; Zhang S; Liu Y; Xiang Y; Liu J; Shi M Oncogene; 2019 Jun; 38(23):4637-4654. PubMed ID: 30742067 [TBL] [Abstract][Full Text] [Related]
7. miR-135a promotes gastric cancer progression and resistance to oxaliplatin. Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111 [TBL] [Abstract][Full Text] [Related]
8. MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells. Yang T; He W; Cui F; Xia J; Zhou R; Wu Z; Zhao Y; Shi M Oncotarget; 2016 Apr; 7(14):18085-94. PubMed ID: 26919111 [TBL] [Abstract][Full Text] [Related]
9. MACC1 upregulation promotes gastric cancer tumor cell metastasis and predicts a poor prognosis. Xie QP; Xiang C; Wang G; Lei KF; Wang Y J Zhejiang Univ Sci B; 2016 May; 17(5):361-6. PubMed ID: 27143263 [TBL] [Abstract][Full Text] [Related]
10. [Establishment of BGC-823/pBaBb-puro-MACC1 gastric cancer cell line stably expressing MACC1 and its tumor-related gene expression profiles]. Wang N; Xie JM; Zheng DY; Zuo Q; Liao WJ Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):312-6. PubMed ID: 22445973 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer. Duan J; Sun L; Huang H; Wu Z; Wang L; Liao W Mol Med Rep; 2016 Apr; 13(4):3027-35. PubMed ID: 26936091 [TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification. Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386 [TBL] [Abstract][Full Text] [Related]
13. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer. Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375 [TBL] [Abstract][Full Text] [Related]
14. Gastric cancer cells escape metabolic stress via the DLC3/MACC1 axis. Lin L; Liu Y; Pan C; Zhang J; Zhao Y; Shao R; Huang Z; Su Y; Shi M; Bin J; Liao Y; Li N; Wang C; Liao W Theranostics; 2019; 9(7):2100-2114. PubMed ID: 31037159 [TBL] [Abstract][Full Text] [Related]
15. S100P enhances the chemosensitivity of human gastric cancer cell lines. Zhao X; Bai Z; Wu P; Zhang Z Cancer Biomark; 2013; 13(1):1-10. PubMed ID: 23736016 [TBL] [Abstract][Full Text] [Related]
16. Metastasis-associated in colon cancer-1 in gastric cancer: Beyond metastasis. Wu ZZ; Chen LS; Zhou R; Bin JP; Liao YL; Liao WJ World J Gastroenterol; 2016 Aug; 22(29):6629-37. PubMed ID: 27547006 [TBL] [Abstract][Full Text] [Related]
17. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841 [TBL] [Abstract][Full Text] [Related]
18. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression. Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581 [TBL] [Abstract][Full Text] [Related]
19. MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect. Lin L; Huang H; Liao W; Ma H; Liu J; Wang L; Huang N; Liao Y; Liao W Oncogene; 2015 May; 34(21):2700-10. PubMed ID: 25043301 [TBL] [Abstract][Full Text] [Related]
20. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy. Tan S; Shi H; Ba M; Lin S; Tang H; Zeng X; Zhang X Int J Mol Med; 2016 Apr; 37(4):1030-8. PubMed ID: 26935807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]